|
ZNF281 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09299244602335E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76299974619099E-10 |
| Normal-vs-Stage2 |
1.32929999996367E-06 |
| Normal-vs-Stage3 |
4.29249968902923E-10 |
| Normal-vs-Stage4 |
1.23819998698593E-09 |
| Stage1-vs-Stage2 |
8.176800E-01 |
| Stage1-vs-Stage3 |
3.064800E-01 |
| Stage1-vs-Stage4 |
8.018000E-02 |
| Stage2-vs-Stage3 |
6.298000E-01 |
| Stage2-vs-Stage4 |
2.926600E-01 |
| Stage3-vs-Stage4 |
4.935000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.91680021749607E-11 |
| Normal-vs-AfricanAmerican |
3.772800E-04 |
| Normal-vs-Asian |
6.70920000001018E-07 |
| Caucasian-vs-AfricanAmerican |
7.131600E-01 |
| Caucasian-vs-Asian |
8.189800E-01 |
| AfricanAmerican-vs-Asian |
6.192800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.37869970784755E-10 |
| Normal-vs-Female |
4.15978362866554E-12 |
| Male-vs-Female |
6.514200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.75919997750185E-09 |
| Normal-vs-Age(41-60Yrs) |
4.08995060041661E-12 |
| Normal-vs-Age(61-80Yrs) |
2.22579998876427E-09 |
| Normal-vs-Age(81-100Yrs) |
9.119800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.186400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.910200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.730800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.723000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.132600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.657000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.228000E-02 |
| Classical-VS-Follicular |
1.168820E-04 |
| Classical-VS-Other |
1.061000E-01 |
| Classical-VS-Normal |
3.18740001059581E-09 |
| Tall-VS-Follicular |
5.061200E-01 |
| Tall-VS-Other |
4.928800E-01 |
| Tall-VS-Normal |
5.53829999971889E-07 |
| Follicular-VS-Other |
7.050200E-01 |
| Follicular-VS-Normal |
2.86050072517696E-11 |
| Other-VS-Normal |
9.838300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71820335737038E-11 |
| Normal-vs-N1 |
4.36330005459951E-09 |
| N0-vs-N1 |
4.665000E-01 |
|
|
